These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33475167)

  • 1. Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.
    Anirudhan V; Lee H; Cheng H; Cooper L; Rong L
    J Med Virol; 2021 May; 93(5):2722-2734. PubMed ID: 33475167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of antiviral drug candidates targeting coronaviral 3C-like main proteases.
    Chen CC; Yu X; Kuo CJ; Min J; Chen S; Ma L; Liu K; Guo RT
    FEBS J; 2021 Sep; 288(17):5089-5121. PubMed ID: 33400393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors.
    He J; Hu L; Huang X; Wang C; Zhang Z; Wang Y; Zhang D; Ye W
    Int J Antimicrob Agents; 2020 Aug; 56(2):106055. PubMed ID: 32534187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors targeting the main protease and papain-like protease of coronaviruses.
    Capasso C; Nocentini A; Supuran CT
    Expert Opin Ther Pat; 2021 Apr; 31(4):309-324. PubMed ID: 33246378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of SARS-CoV-2 papain-like protease (PL
    Garnsey MR; Robinson MC; Nguyen LT; Cardin R; Tillotson J; Mashalidis E; Yu A; Aschenbrenner L; Balesano A; Behzadi A; Boras B; Chang JS; Eng H; Ephron A; Foley T; Ford KK; Frick JM; Gibson S; Hao L; Hurst B; Kalgutkar AS; Korczynska M; Lengyel-Zhand Z; Gao L; Meredith HR; Patel NC; Polivkova J; Rai D; Rose CR; Rothan H; Sakata SK; Vargo TR; Qi W; Wu H; Liu Y; Yurgelonis I; Zhang J; Zhu Y; Zhang L; Lee AA
    Sci Adv; 2024 Aug; 10(35):eado4288. PubMed ID: 39213347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Updated Review on SARS-CoV-2 Main Proteinase (M
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding SARS-CoV-2 Transmission and Evolution and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine.
    Wang R; Hozumi Y; Yin C; Wei GW
    J Chem Inf Model; 2020 Dec; 60(12):5853-5865. PubMed ID: 32530284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease.
    Su H; Yao S; Zhao W; Zhang Y; Liu J; Shao Q; Wang Q; Li M; Xie H; Shang W; Ke C; Feng L; Jiang X; Shen J; Xiao G; Jiang H; Zhang L; Ye Y; Xu Y
    Nat Commun; 2021 Jun; 12(1):3623. PubMed ID: 34131140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure-activity relationships.
    Kerti L; Frecer V
    Bioorg Med Chem; 2024 Nov; 113():117909. PubMed ID: 39288705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development.
    Zhu W; Shyr Z; Lo DC; Zheng W
    J Pharmacol Exp Ther; 2021 Aug; 378(2):166-172. PubMed ID: 33972366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.
    Brier L; Hassan H; Hanoulle X; Landry V; Moschidi D; Desmarets L; Rouillé Y; Dumont J; Herledan A; Warenghem S; Piveteau C; Carré P; Ikherbane S; Cantrelle FX; Dupré E; Dubuisson J; Belouzard S; Leroux F; Deprez B; Charton J
    Eur J Med Chem; 2023 Mar; 250():115186. PubMed ID: 36796300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
    Dampalla CS; Zheng J; Perera KD; Wong LR; Meyerholz DK; Nguyen HN; Kashipathy MM; Battaile KP; Lovell S; Kim Y; Perlman S; Groutas WC; Chang KO
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34210738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-chymotrypsin-like protease in SARS-CoV-2.
    Al Adem K; Ferreira JC; Villanueva AJ; Fadl S; El-Sadaany F; Masmoudi I; Gidiya Y; Gurudza T; Cardoso THS; Saksena NK; Rabeh WM
    Biosci Rep; 2024 Aug; 44(8):. PubMed ID: 39036877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting novel structural and functional features of coronavirus protease nsp5 (3CL
    Roe MK; Junod NA; Young AR; Beachboard DC; Stobart CC
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33507143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.